Flexion Therapeutics Inc. (Nasdaq: FLXN)

https://www.flexiontherapeutics.com

Flexion Therapeutics (Nasdaq:FLXN) is a specialty pharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with OA, a type of degenerative arthritis. The company's core values are focus, ingenuity, tenacity, transparency and fun. Flexion was named one of the Boston Business Journal's 2017 Best Places to Work and one of the Top Places to Work in Massachusetts by The Boston Globe. *

	Start	2017-12-13 existent
	Industry	pharmaceutical
	Industry 2	gene therapy
	Person	Clayman, Michael (Flexion Therapeutics 201712 CEO)

	Street	10 Mall Road Suite 301
	City	01803 Burlington, MA
	Tel	+1-781-305-7777
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Flexion Therapeutics, Inc.. (12/13/17). "Press Release: Flexion Therapeutics Announces Acquisition of Novel, Non-Opioid Asset for Osteoarthritis of the Knee". Burlington, MA.

		Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]